Dwayne Watkins, MD
Internal Medicine · Griffin, GANPI 1174543276
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $7,956 of the $8,216 with a category attached, or 96.8%. AbbVie accounts for 96.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $7,993 and has fallen 99.4% since, to $52 in 2022. Among internal medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $586.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Boehringer Ingelheim$94
- Novo Nordisk$44
- Kvk-tech, Inc.$44
- Lilly USA, LLC$37
- Kowa Pharmaceuticals America, Inc.$21
- plus $20 from 1 others
Across 39 payments — averaging $30,401 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$906K
- Taro Pharmaceuticals USA, Inc.$268K
- Alnylam Pharmaceuticals Inc.$12K
What the payments were for
- Food & beverage$2603%
- Gifts$7,95697%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1 | $7,956 |
| Boehringer Ingelheim | 5 | $94 |
| Novo Nordisk | 2 | $44 |
| Kvk-tech, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| AstraZeneca | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$7,956
How this compares
$8,216 in reported general payments places this provider in the 90th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 23 | $227 |
| Naproxen | 15 | $144 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $104 |
| Ondansetron OdtOndansetron | 13 | $64 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $61 |
| Levofloxacin | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Griffin
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.